News

By renewing our driver’s license at the DMV, most of us are aware of the process of registering to become an organ donor should the worst come to pass. But there is another group of organ donors — living donors — who are helping relatives, friends and even strangers by donating a kidney or part of their liver. Living donors who choose to give a kidney — the most commonly donated organ — can live a full life with the remaining kidney.

For all we know about multiple sclerosis (MS) – a chronic disease where a person’s immune system attacks their central nervous system and causes fatigue, bladder issues and pain, among other symptoms – there are still a lot of misconceptions around the condition. Read on to learn what’s fact and what’s fiction when it comes to MS.

It’s no secret that when women are healthy, families and communities thrive. But from menstruation to menopause, women face many distinct — and sometimes complex — health events that require care, understanding and partnership from a health care provider.

When it comes to stroke, it’s crucial to know how to recognize its signs and symptoms so you can access care quickly and preserve brain function. One acronym — BE FAST — can make it easier to identify a stroke, which happens when there’s a blockage to the brain’s blood supply (an ischemic stroke) or a sudden rupture and bleeding in the brain (a hemorrhagic stroke).

BE FAST stands for:

Every February, a very famous football game consumes the general American public. Football is a beloved sport and pastime that celebrates athleticism and teamwork and captures the imaginations of kids who have dreams of going pro. But as The Big Game has grown in size and spectacle over the years, more concern has bubbled up over head injuries, like concussions, in football.

There’s a lot to love about football, but there are also safety factors to consider — as there are with any sport. Here’s what to know about concussions and football.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.